Groundbreaking Study Employing Sensonics International’s Products Reveals Weight Loss Medications Impair Taste Function

PHILADELPHIA, Jan. 30, 2025 /PRNewswire/ — A new study published in Physiology & Behavior uncovers significant sensory implications of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications commonly prescribed for weight loss and obesity management. Researchers at the…